Analyses of Potential Predictive Markers and Response to Targeted Therapy in Patients with Advanced Clear-cell Renal Cell Carcinoma
Background: Vascular endothelial growth factor-targeted agents are standard treatments in advanced clear-cell renal cell carcinoma (ccRCC), but biomarkers of activity are lacking. The aim of this study was to investigate the association of Von Hippel-Lindau (VHL) gene status, vascular endothelial gr...
Main Authors: | Yan Song, Jing Huang, Ling Shan, Hong-Tu Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2015-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=15;spage=2026;epage=2033;aulast=Song |
Similar Items
-
Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
by: Kenan Ashouri, et al.
Published: (2015-09-01) -
A Painful Finger: An Unusual Presentation of Von Hippel-Lindau-Associated Advanced Renal Cell Carcinoma
by: Pui San Sarah Ho, et al.
Published: (2020-03-01) -
Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
by: Hyeong Su Kim, et al.
Published: (2018-08-01) -
MicroRNAs Associated with Von Hippel–Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review
by: Lisa-Maria Schanza, et al.
Published: (2017-11-01) -
Identification of Somatic Mutations in the von Hippel–Lindau (VHL) Gene in a Patient With Renal Cell Carcinoma
by: Wen-Chung Wang, et al.
Published: (2009-11-01)